USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE
The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extra...
Saved in:
Main Authors | , , , , , , , |
---|---|
Format | Patent |
Language | English French German |
Published |
10.01.2024
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extranodal NKTCL is initial-treating, relapsed, and refractory extranodal nasal NKTCL. On this basis, other first-line and second-line drugs for treating NKTCL can also be further used. The present invention further provides a method for treating NKTCL. The method relates to administering therapeutically effective amounts of mitoxantrone hydrochloride liposome and pegaspargase to a patient. The mitoxantrone hydrochloride liposome improves the curative effect of pegaspargase on NKTCL, has little toxic and side effects, and increases the complete response rate (CR rate) and the partial response rate (PR rate) of diseases. |
---|---|
AbstractList | The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The NKTCL comprises initial-treating, relapsed, and refractory extranodal NKTCL. Preferably, the initial-treating, relapsed, and refractory extranodal NKTCL is initial-treating, relapsed, and refractory extranodal nasal NKTCL. On this basis, other first-line and second-line drugs for treating NKTCL can also be further used. The present invention further provides a method for treating NKTCL. The method relates to administering therapeutically effective amounts of mitoxantrone hydrochloride liposome and pegaspargase to a patient. The mitoxantrone hydrochloride liposome improves the curative effect of pegaspargase on NKTCL, has little toxic and side effects, and increases the complete response rate (CR rate) and the partial response rate (PR rate) of diseases. |
Author | LI, Yanhui ZHOU, Meng YANG, Shasha WANG, Shixia XIA, Xuefang LIN, Hongmei LI, Chunlei YAN, Shujie |
Author_xml | – fullname: YANG, Shasha – fullname: YAN, Shujie – fullname: WANG, Shixia – fullname: LI, Chunlei – fullname: LIN, Hongmei – fullname: ZHOU, Meng – fullname: XIA, Xuefang – fullname: LI, Yanhui |
BookMark | eNrjYmDJy89L5WSwDg12VfB3U_D1DPGPcPQLCfL3c1XwiHQJ8nf28PEP8nRxVfDxDPAP9vd1VXD0c1EIcHV3DA5wDAKSrjwMrGmJOcWpvFCam0HBzTXE2UM3tSA_PrW4IDE5NS-1JN41wMTQwsDA1NTRxJgIJQC0hSrk |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | VERWENDUNG VON MITOXANTRONHYDROCHLORIDLIPOSOM UND PEGASPARGASE UTILISATION DE LIPOSOME DE CHLORHYDRATE DE MITOXANTRONE ET PÉGASPARGASE |
ExternalDocumentID | EP4180055A4 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_EP4180055A43 |
IEDL.DBID | EVB |
IngestDate | Fri Sep 20 10:14:55 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French German |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_EP4180055A43 |
Notes | Application Number: EP20210854523 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&CC=EP&NR=4180055A4 |
ParticipantIDs | epo_espacenet_EP4180055A4 |
PublicationCentury | 2000 |
PublicationDate | 20240110 |
PublicationDateYYYYMMDD | 2024-01-10 |
PublicationDate_xml | – month: 01 year: 2024 text: 20240110 day: 10 |
PublicationDecade | 2020 |
PublicationYear | 2024 |
RelatedCompanies | CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd |
RelatedCompanies_xml | – name: CSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co., Ltd |
Score | 3.522222 |
Snippet | The present invention provides use of mitoxantrone hydrochloride liposome and pegaspargase in preparation of drug for treating NK/T-cell lymphoma (NKTCL). The... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | USE OF MITOXANTRONE HYDROCHLORIDE LIPOSOME AND PEGASPARGASE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240110&DB=EPODOC&locale=&CC=EP&NR=4180055A4 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp-L8Ig_St2I_kq0iQ7omtYprSrfJfBr9yGAv3XAV_32vZZu-6Es4EjguB3e_3CV3Abi1Fc1Yzmzdprmj0yRh-r3hZLpKUstOul0jrxP6g7ATjOnLhE0aMN_UwtR9Qr_q5ohoURnae1n76-VPEovXbytXd-kcpxaP_qjHtXV0jPCEcKbxfk9EkktP8zyktDDuUdOp2k25dAd2q1N01WZfvPWropTlb0Txj2AvQmZFeQwNVbTgwNt8vNaC_cH6vhvJtemtTuBhPBRE-gR9jZy44SiWoSDBO4-lF7zK-JkLgkG6HMqBIG7ISSSe3GHkxjiKUyC-GHmBjlJMtzueimgrr30GzWJRqHMgVmYzp6PYjCYWZWnqJKY9sxwjMxWidIe2of0nm4t_1i7hsFJdlVgwjStolh-f6hqhtkxvaiV9AyfwfPY |
link.rule.ids | 230,309,786,891,25594,76904 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFOebTsX5mQfpW7EfyVaRIV2b2unalK6T7Wm0XQd76Yar-O97Ldv0RV_CkcCRHNz9uEvuF4B7PaMpmzFd1unMkGkcM_lRMVI5ixNNjzsdZVYV9D2_7Y7o65iNa7DY9sJUPKFfFTkielSK_l5U8Xr1U8Syq7eV64dkgVPLZyfq2tImO0Z4QjiT7F6XB8IWlmRZKEl-2KWqUdJNmXQP9juYEZY0-_y9VzalrH4jinMMBwEqy4sTqGV5ExrW9uO1Jhx6m_tuFDeutz6Fp9GQE-EQjDVibPpRKHxO3IkdCssdiLBvc4JJuhgKjxPTt0nAX8xhYIY48jMgDo8sV8ZdTHcnnvJgt1_9HOr5Ms8ugGipzox2xuY01ihLEiNW9blmKKmaIUq3aQtaf6q5_GftDhpu5A2mg77_dgVHpRnLIoOqXEO9-PjMbhB2i-S2Mtg3Ji5_4Q |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=USE+OF+MITOXANTRONE+HYDROCHLORIDE+LIPOSOME+AND+PEGASPARGASE&rft.inventor=YANG%2C+Shasha&rft.inventor=YAN%2C+Shujie&rft.inventor=WANG%2C+Shixia&rft.inventor=LI%2C+Chunlei&rft.inventor=LIN%2C+Hongmei&rft.inventor=ZHOU%2C+Meng&rft.inventor=XIA%2C+Xuefang&rft.inventor=LI%2C+Yanhui&rft.date=2024-01-10&rft.externalDBID=A4&rft.externalDocID=EP4180055A4 |